Short description
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.
Description
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space. It provides the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms, including API, medical, pharmaceutical, and derma cosmetics. As a multinational organization with vertical integration, Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions.
Avicanna was founded in 2016 and is headquartered in Toronto, Ontario, Canada.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Toronto, Ontario, Canada, North America
Founded on
January 1, 2016
Exited on
July 19, 2019
Went public on
July 19, 2019
Stock symbol
AVCN
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Blurry Noaccess, No Way, Noaccess, No Way, Noway Youcantaccess, No Way
Sign in for full access
Founders
Aras Azadian, Setu Purohit